Abstract
Background: Hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) are a new class of treatment for renal anemia in patients with chronic k......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
